Mariam Assi

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Fnu Shweta et al. · Mayo Clinic Proceedings · 2020 · 86 citations · Full text

Gm-csf Neutralization, Immunology, Infectious Respiratory Disease +4

Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19

Cristina Corsini Campioli, Edison Cano Cevallos, Mariam Assi et al. · Journal of Clinical Virology · 2020 · 59 citations · Full text

Viral Persistence, Viral Diagnostics, Covid-19 Pandemic +8

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

John C. O’Horo, James R. Cerhan, Elliot J. Cahn et al. · Mayo Clinic Proceedings · 2020 · 31 citations · Full text

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Paschalis Vergidis et al. · 2020 · 26 citations · Full text

Impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections: An update and perspective

Mariam Assi, Michelle Doll, Rachel Pryor et al. · Infection Control and Hospital Epidemiology · 2021 · 17 citations · Full text